These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16687053)

  • 1. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
    J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
    Zivadinov R; Grop A; Sharma J; Bratina A; Tjoa CW; Dwyer M; Zorzon M
    J Neuroimaging; 2005 Jan; 15(1):27-36. PubMed ID: 15574571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
    J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
    Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H;
    J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.
    Dolezal O; Dwyer MG; Horakova D; Havrdova E; Minagar A; Balachandran S; Bergsland N; Seidl Z; Vaneckova M; Fritz D; Krasensky J; Zivadinov R
    Int Rev Neurobiol; 2007; 79():475-89. PubMed ID: 17531855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
    Jasperse B; Valsasina P; Neacsu V; Knol DL; De Stefano N; Enzinger C; Smith SM; Ropele S; Korteweg T; Giorgio A; Anderson V; Polman CH; Filippi M; Miller DH; Rovaris M; Barkhof F; Vrenken H;
    J Magn Reson Imaging; 2007 Oct; 26(4):881-5. PubMed ID: 17896359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening.
    Janardhan V; Suri S; Bakshi R
    Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
    Dolezal O; Gabelic T; Horakova D; Bergsland N; Dwyer MG; Seidl Z; Krasensky J; Ramasamy DP; Vaneckova M; Havrdova E; Zivadinov R
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S42-8. PubMed ID: 24321154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
    Hardmeier M; Wagenpfeil S; Freitag P; Fisher E; Rudick RA; Kooijmans-Coutinho M; Clanet M; Radue EW; Kappos L;
    Arch Neurol; 2003 Dec; 60(12):1736-9. PubMed ID: 14676048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
    Nakamura K; Brown RA; Narayanan S; Collins DL; Arnold DL;
    Neuroimage; 2015 Sep; 118():126-32. PubMed ID: 26049148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.
    Pichler A; Khalil M; Langkammer C; Pinter D; Bachmaier G; Ropele S; Fuchs S; Enzinger C; Fazekas F
    Mult Scler; 2016 Mar; 22(3):340-6. PubMed ID: 26163072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation.
    Sharma J; Sanfilipo MP; Benedict RH; Weinstock-Guttman B; Munschauer FE; Bakshi R
    AJNR Am J Neuroradiol; 2004; 25(6):985-96. PubMed ID: 15205136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain volume loss in individuals over time: Source of variance and limits of detectability.
    Narayanan S; Nakamura K; Fonov VS; Maranzano J; Caramanos Z; Giacomini PS; Collins DL; Arnold DL
    Neuroimage; 2020 Jul; 214():116737. PubMed ID: 32171923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.